{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T01:42:11Z","timestamp":1769478131108,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Provincial-level talent program for National center of technology innovation for bio pharmaceuticals","award":["NCTIB2024JS0101"],"award-info":[{"award-number":["NCTIB2024JS0101"]}]},{"name":"Graduate Cross-Innovation Program Suzhou Medical College of Soochow University","award":["20244232055"],"award-info":[{"award-number":["20244232055"]}]},{"name":"Suzhou Medical College-QiLu Medical Research Program of Soochow University","award":["24QL200103"],"award-info":[{"award-number":["24QL200103"]}]},{"name":"Prof. Changgeng Ruan's Research and Innovation Fund for Graduate Students of the First Affiliated Hospital of Soochow University","award":["RKYCX202405"],"award-info":[{"award-number":["RKYCX202405"]}]},{"name":"Boxi Clinical Research The First Affiliated Hospital of Soochow University","award":["BXLC2024022"],"award-info":[{"award-number":["BXLC2024022"]}]},{"name":"Jiangsu Province Chinese Traditional Medicine Science and Technology Development Plan Project","award":["MS2025123"],"award-info":[{"award-number":["MS2025123"]}]},{"name":"Suzhou Basic Research Pilot Project","award":["SSD2024047"],"award-info":[{"award-number":["SSD2024047"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15489-8","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T11:39:24Z","timestamp":1766403564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Methylmalonic acid modulates neutrophil function to promote tumor progression in colorectal cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Fang","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxiang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huihui","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuwei","family":"Mi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baoan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinmiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songbing","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"issue":"1","key":"15489_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"15489_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"15489_CR3","doi-asserted-by":"publisher","first-page":"808964","DOI":"10.3389\/fimmu.2021.808964","volume":"12","author":"Z Bai","year":"2021","unstructured":"Bai Z, Zhou Y, Ye Z, Xiong J, Lan H, Wang F. Tumor-Infiltrating lymphocytes in colorectal cancer: the fundamental indication and application on immunotherapy. Front Immunol. 2021;12:808964.","journal-title":"Front Immunol"},{"key":"15489_CR4","doi-asserted-by":"publisher","first-page":"612826","DOI":"10.3389\/fimmu.2021.612826","volume":"12","author":"M Hanus","year":"2021","unstructured":"Hanus M, Parada-Venegas D, Landskron G, Wielandt AM, Hurtado C, Alvarez K, et al. Immune System, Microbiota, and microbial metabolites: the unresolved triad in colorectal cancer microenvironment. Front Immunol. 2021;12:612826.","journal-title":"Front Immunol"},{"issue":"12","key":"15489_CR5","doi-asserted-by":"publisher","first-page":"6262","DOI":"10.3390\/ijms22126262","volume":"22","author":"M Nenkov","year":"2021","unstructured":"Nenkov M, Ma Y, Ga\u00dfler N, Chen Y. Metabolic reprogramming of colorectal cancer cells and the microenvironment: implication for therapy. Int J Mol Sci. 2021;22(12):6262.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"15489_CR6","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1158\/1078-0432.CCR-18-1851","volume":"26","author":"HK Angell","year":"2020","unstructured":"Angell HK, Bruni D, Barrett JC, Herbst R, Galon J. The immunoscore: colon cancer and beyond. Clin Cancer Res. 2020;26(2):332\u20139.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"15489_CR7","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","volume":"14","author":"WH Fridman","year":"2017","unstructured":"Fridman WH, Zitvogel L, Saut\u00e8s-Fridman C, Kroemer G. The immune contexture in cancer prognosis and treatment. Nat Rev Clin Oncol. 2017;14(12):717\u201334.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"15489_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/ijms26010006","volume":"26","author":"H Masui","year":"2024","unstructured":"Masui H, Kawada K, Obama K. Neutrophil and colorectal cancer. Int J Mol Sci. 2024;26(1):6.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"15489_CR9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s43018-025-00910-9","volume":"6","author":"Q Li","year":"2025","unstructured":"Li Q, Xiao Y, Han L, Luo W, Dai W, Fang H, et al. Microbiome dysbiosis, neutrophil recruitment and mesenchymal transition of mesothelial cells promotes peritoneal metastasis of colorectal cancer. Nat Cancer. 2025;6(3):493\u2013510.","journal-title":"Nat Cancer"},{"issue":"4","key":"15489_CR10","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.cmet.2024.12.013","volume":"37","author":"X Zhu","year":"2025","unstructured":"Zhu X, Hu M, Huang X, Li L, Lin X, Shao X, et al. Interplay between gut microbial communities and metabolites modulates pan-cancer immunotherapy responses. Cell Metab. 2025;37(4):806\u2013e823806.","journal-title":"Cell Metab"},{"issue":"5","key":"15489_CR11","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1136\/gutjnl-2024-333020","volume":"74","author":"K Nan","year":"2025","unstructured":"Nan K, Zhong Z, Yue Y, Shen Y, Zhang H, Wang Z, et al. Fasting-mimicking diet-enriched bifidobacterium pseudolongum suppresses colorectal cancer by inducing memory CD8(+) T cells. Gut. 2025;74(5):775\u201386.","journal-title":"Gut"},{"key":"15489_CR12","doi-asserted-by":"publisher","first-page":"107494","DOI":"10.1016\/j.phrs.2024.107494","volume":"210","author":"X Mi","year":"2024","unstructured":"Mi X, Duan Y, Sun J, Tai Q, Yao H, Meng L, et al. The ketogenic diet modulates tumor-associated neutrophil polarization via the AMOT-YAP\/TAZ axis to inhibit colorectal cancer progression. Pharmacol Res. 2024;210:107494.","journal-title":"Pharmacol Res"},{"issue":"10","key":"15489_CR13","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1089\/hum.2019.113","volume":"30","author":"RJ Chandler","year":"2019","unstructured":"Chandler RJ, Venditti CP. Gene therapy for methylmalonic acidemia: Past, Present, and future. Hum Gene Ther. 2019;30(10):1236\u201344.","journal-title":"Hum Gene Ther"},{"issue":"1","key":"15489_CR14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12935-023-02973-z","volume":"23","author":"C Hu","year":"2023","unstructured":"Hu C, Ye M, Bai J, Liu P, Lu F, Chen J, et al. Methylmalonic acid promotes colorectal cancer progression via activation of Wnt\/\u03b2-catenin pathway mediated epithelial-mesenchymal transition. Cancer Cell Int. 2023;23(1):131.","journal-title":"Cancer Cell Int"},{"key":"15489_CR15","first-page":"101909","volume":"41","author":"AR Tanaka","year":"2025","unstructured":"Tanaka AR, Murakami C, Yamamoto H. Methylmalonic acid at the serum level in the elderly contributes to cell growth via mitochondrial dysfunction in colorectal cancer cell spheroids. Biochem Biophys Rep. 2025;41:101909.","journal-title":"Biochem Biophys Rep"},{"issue":"2","key":"15489_CR16","doi-asserted-by":"publisher","first-page":"e0297758","DOI":"10.1371\/journal.pone.0297758","volume":"19","author":"SB Bhakta","year":"2024","unstructured":"Bhakta SB, Lundgren SM, Sesti BN, Flores BA, Akdogan E, Collins SR, et al. Neutrophil-like cells derived from the HL-60 cell-line as a genetically-tractable model for neutrophil degranulation. PLoS ONE. 2024;19(2):e0297758.","journal-title":"PLoS ONE"},{"issue":"4","key":"15489_CR17","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s42255-022-00540-w","volume":"4","author":"EJ Kay","year":"2022","unstructured":"Kay EJ, Zanivan S. Methylmalonic acid: an age-related metabolite that drives tumour aggressiveness. Nat Metab. 2022;4(4):412\u20133.","journal-title":"Nat Metab"},{"issue":"6","key":"15489_CR18","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1007\/s11255-024-03944-7","volume":"56","author":"G Lin","year":"2024","unstructured":"Lin G, Zhan F, Jin L, Liu G, Wei W. The association between methylmalonic acid, a biomarker of mitochondrial dysfunction, and risk of prostate cancer. Int Urol Nephrol. 2024;56(6):1879\u201385.","journal-title":"Int Urol Nephrol"},{"issue":"33","key":"15489_CR19","doi-asserted-by":"publisher","first-page":"e2308711","DOI":"10.1002\/advs.202308711","volume":"11","author":"F Chen","year":"2024","unstructured":"Chen F, Zhang K, Wang M, He Z, Yu B, Wang X, et al. VEGF-FGF signaling activates quiescent CD63(+) liver stem cells to proliferate and differentiate. Adv Sci (Weinh). 2024;11(33):e2308711.","journal-title":"Adv Sci (Weinh)"},{"issue":"2","key":"15489_CR20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41418-024-01256-y","volume":"31","author":"Y He","year":"2024","unstructured":"He Y, Shi Q, Ling Y, Guo H, Fei Y, Wu R, et al. ABLIM1, a novel ubiquitin E3 ligase, promotes growth and metastasis of colorectal cancer through targeting I\u0138B\u03b1 ubiquitination and activating NF-\u0138B signaling. Cell Death Differ. 2024;31(2):203\u201316.","journal-title":"Cell Death Differ"},{"issue":"14","key":"15489_CR21","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1111\/febs.16768","volume":"290","author":"L Zhou","year":"2023","unstructured":"Zhou L, Ou S, Liang T, Li M, Xiao P, Cheng J, et al. MAEL facilitates metabolic reprogramming and breast cancer progression by promoting the degradation of citrate synthase and fumarate hydratase via chaperone-mediated autophagy. Febs J. 2023;290(14):3614\u201328.","journal-title":"Febs J"},{"issue":"1","key":"15489_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2012.04.144","volume":"422","author":"M Chypre","year":"2012","unstructured":"Chypre M, Zaidi N, Smans K. ATP-citrate lyase: a mini-review. Biochem Biophys Res Commun. 2012;422(1):1\u20134.","journal-title":"Biochem Biophys Res Commun"},{"key":"15489_CR23","doi-asserted-by":"publisher","first-page":"932154","DOI":"10.3389\/fphar.2022.932154","volume":"13","author":"Q Meng","year":"2022","unstructured":"Meng Q, Zhang Y, Hao S, Sun H, Liu B, Zhou H, et al. Recent findings in the regulation of G6PD and its role in diseases. Front Pharmacol. 2022;13:932154.","journal-title":"Front Pharmacol"},{"key":"15489_CR24","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.bbrc.2023.05.108","volume":"671","author":"W Ma","year":"2023","unstructured":"Ma W, Liu R, Zhao K, Zhong J. Vital role of SHMT2 in diverse disease. Biochem Biophys Res Commun. 2023;671:160\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"15489_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41423-023-00974-6","volume":"20","author":"S Cambier","year":"2023","unstructured":"Cambier S, Gouwy M, Proost P. The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards Pharmacological intervention. Cell Mol Immunol. 2023;20(3):217\u201351.","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"15489_CR26","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.tcb.2022.07.006","volume":"33","author":"SK Das","year":"2023","unstructured":"Das SK, Lewis BA, Levens D. MYC: a complex problem. Trends Cell Biol. 2023;33(3):235\u201346.","journal-title":"Trends Cell Biol"},{"issue":"2 Pt 1","key":"15489_CR27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.gene.2015.08.063","volume":"575","author":"M Haase","year":"2016","unstructured":"Haase M, Fitze G. HSP90AB1: helping the good and the bad. Gene. 2016;575(2 Pt 1):171\u201386.","journal-title":"Gene"},{"key":"15489_CR28","doi-asserted-by":"publisher","first-page":"115020","DOI":"10.1016\/j.ejmech.2022.115020","volume":"247","author":"BR Chahat","year":"2023","unstructured":"Chahat BR, Kumar B. p53 as a potential target for treatment of cancer: A perspective on recent advancements in small molecules with structural insights and SAR studies. Eur J Med Chem. 2023;247:115020.","journal-title":"Eur J Med Chem"},{"key":"15489_CR29","doi-asserted-by":"publisher","first-page":"105553","DOI":"10.1016\/j.neuint.2023.105553","volume":"167","author":"P Gong","year":"2023","unstructured":"Gong P, Jia HY, Li R, Ma Z, Si M, Qian C, et al. Downregulation of Nogo-B ameliorates cerebral ischemia\/reperfusion injury in mice through regulating microglia polarization via TLR4\/NF-kappaB pathway. Neurochem Int. 2023;167:105553.","journal-title":"Neurochem Int"},{"issue":"6","key":"15489_CR30","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.7150\/thno.15625","volume":"7","author":"H Ha","year":"2017","unstructured":"Ha H, Debnath B, Neamati N. Role of the CXCL8-CXCR1\/2 axis in cancer and inflammatory diseases. Theranostics. 2017;7(6):1543\u201388.","journal-title":"Theranostics"},{"key":"15489_CR31","doi-asserted-by":"publisher","first-page":"100909","DOI":"10.1016\/j.drup.2022.100909","volume":"66","author":"Y Di","year":"2023","unstructured":"Di Y, Jing X, Hu K, Wen X, Ye L, Zhang X, et al. The c-MYC-WDR43 signalling axis promotes chemoresistance and tumour growth in colorectal cancer by inhibiting p53 activity. Drug Resist Updat. 2023;66:100909.","journal-title":"Drug Resist Updat"},{"key":"15489_CR32","doi-asserted-by":"publisher","first-page":"115690","DOI":"10.1016\/j.biopha.2023.115690","volume":"168","author":"J Li","year":"2023","unstructured":"Li J, Shang L, Zhou F, Wang S, Liu N, Zhou M, et al. Herba patriniae and its component isovitexin show anti-colorectal cancer effects by inducing apoptosis and cell-cycle arrest via p53 activation. Biomed Pharmacother. 2023;168:115690.","journal-title":"Biomed Pharmacother"},{"key":"15489_CR33","doi-asserted-by":"publisher","first-page":"1581398","DOI":"10.3389\/fimmu.2025.1581398","volume":"16","author":"X Peng","year":"2025","unstructured":"Peng X, Liu Z, Luo C, Sun R, Zhang Y, Li B, et al. PSMD12 promotes hepatocellular carcinoma progression by stabilizing CDK1. Front Immunol. 2025;16:1581398.","journal-title":"Front Immunol"},{"key":"15489_CR34","doi-asserted-by":"publisher","first-page":"757872","DOI":"10.3389\/fimmu.2021.757872","volume":"12","author":"V Dur\u00e1n-Laforet","year":"2021","unstructured":"Dur\u00e1n-Laforet V, Pe\u00f1a-Mart\u00ednez C, Garc\u00eda-Culebras A, Cuartero MI, Lo EH, Moro M, et al. Role of TLR4 in neutrophil dynamics and functions: contribution to stroke pathophysiology. Front Immunol. 2021;12:757872.","journal-title":"Front Immunol"},{"issue":"9","key":"15489_CR35","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3390\/curroncol32090496","volume":"32","author":"C Sherry","year":"2025","unstructured":"Sherry C, Dadgar N, Liu Z, Fan Y, Xiao K, Zaidi AH, et al. The Interleukin-8-CXCR1\/2 axis as a therapeutic target in peritoneal carcinomatosis. Curr Oncol. 2025;32(9):496.","journal-title":"Curr Oncol"},{"issue":"19","key":"15489_CR36","doi-asserted-by":"publisher","first-page":"4755","DOI":"10.3390\/cancers14194755","volume":"14","author":"W Zheng","year":"2022","unstructured":"Zheng W, Wu J, Peng Y, Sun J, Cheng P, Huang Q. Tumor-Associated neutrophils in colorectal cancer Development, progression and immunotherapy. Cancers (Basel). 2022;14(19):4755.","journal-title":"Cancers (Basel)"},{"key":"15489_CR37","doi-asserted-by":"publisher","first-page":"1612186","DOI":"10.3389\/pore.2025.1612186","volume":"31","author":"JM Ott","year":"2025","unstructured":"Ott JM, Gassenmaier V, Bitzer M, Sch\u00fcrch CM, Heitmann JS, Hagelstein I. B7-H3: a consistent marker in metastatic colorectal cancer with potential for targeted treatment. Pathol Oncol Res. 2025;31:1612186.","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"15489_CR38","doi-asserted-by":"publisher","first-page":"13208","DOI":"10.1038\/s41598-025-89591-z","volume":"15","author":"M Sassano","year":"2025","unstructured":"Sassano M, Seyyedsalehi MS, Hadji M, Rashidian H, Naghibzadeh-Tahami A, Haghdoost AA, et al. Dietary patterns and colorectal cancer: a multicenter case-control study in an Iranian population. Sci Rep. 2025;15(1):13208.","journal-title":"Sci Rep"},{"issue":"9\u201310","key":"15489_CR39","doi-asserted-by":"publisher","first-page":"e24931","DOI":"10.1002\/jcla.24931","volume":"37","author":"N Eivazi","year":"2023","unstructured":"Eivazi N, Mirfakhraie R, Nazemalhosseini Mojarad E, Behroozi J, Yassaee VR, Tahmaseb M, et al. Association of HOTAIR rs2366152 and rs1899663 polymorphisms with colorectal cancer susceptibility in Iranian population: A case-control study. J Clin Lab Anal. 2023;37(9\u201310):e24931.","journal-title":"J Clin Lab Anal"},{"issue":"189","key":"15489_CR40","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.24976\/Discov.Med.202436189.190","volume":"36","author":"SG Kim","year":"2024","unstructured":"Kim SG, Duong TV, Lee S, Ryu KJ, Kwon HK, Park HS. Synergistic Inhibition of colorectal cancer cells by autocrine motility factor peptide and glycyrrhetinic acid. Discov Med. 2024;36(189):2063\u201370.","journal-title":"Discov Med"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15489-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15489-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15489-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T15:28:34Z","timestamp":1769441314000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-025-15489-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15489"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15489-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal and human studies were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and the Declaration of Helsinki, respectively. The protocols were approved by the Ethics Committee of the Hospital of Sihong in Jiangsu (Animal Approval Number: 2023127; Human Approval Number: 2023\u2009\u2212\u20090158). Informed consent was obtained from all human participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"124"}}